Orthocell Limited (ASX:OCC)
Australia · Delayed Price · Currency is AUD 0.5800
-0.0150 (-2.52%)
Nov 11, 2026, 4:10 PM AEDT
Orthocell Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, Orthocell stock has a consensus rating of "Buy" and an average price target of $0.90. The average 1-year stock price forecast is 55.17% higher than the current stock price, while the lowest is $0.65 (+12.07%) and the highest is $1.15 (+98.28%).
Price Target: $0.90 (+55.17%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Orthocell stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bell Potter | Bell Potter | Hold Downgrades $1.13 → $0.65 | Hold | Downgrades | $1.13 → $0.65 | +12.07% | Oct 26, 2026 |
Financial Forecast
Revenue This Year
15.95M
from 11.41M
Increased by 39.82%
Revenue Next Year
30.65M
from 15.95M
Increased by 92.16%
EPS This Year
-0.05
from -0.05
EPS Next Year
-0.02
from -0.05
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is AUD.